1-methyl-3-isobutylxanthine has been researched along with ciprostene in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Conanan, LB; Crutchley, DJ; Solomon, DE | 1 |
Hattori, R; Kawai, C; Shirotani, M; Yui, Y | 1 |
2 other study(ies) available for 1-methyl-3-isobutylxanthine and ciprostene
Article | Year |
---|---|
Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP-1 via a cyclic AMP-dependent mechanism.
Topics: 1-Methyl-3-isobutylxanthine; Bucladesine; Colforsin; Cyclic AMP; Endotoxins; Epoprostenol; Fluorescent Antibody Technique; Humans; Iloprost; Interleukin-1; Monocytes; Prostaglandins, Synthetic; Thromboplastin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1992 |
U-61,431F, a stable prostacyclin analogue, inhibits the proliferation of bovine vascular smooth muscle cells with little antiproliferative effect on endothelial cells.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Aorta; Cattle; Cell Division; Cells, Cultured; Cyclic AMP; DNA Replication; Endothelium, Vascular; Epoprostenol; Kinetics; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Prostaglandins, Synthetic; Thymidine; Tritium | 1991 |